Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethanol | HCID 702 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | HCID 10132459 | HCID 10132459 | — |
| Product | HCID 10133536 | HCID 10133536 | — |
Reaction Steps
To a suspension of 3-chloro-4-(5H,11H-pyrrolo-[2,1-c][1,4]-benzodiazepine-10-carbonyl)-benzonitrile (90.72 g) in ethanol was added 10 N sodium hydroxide (1.02 ml) and the mixture heated under reflux for two hours. The solvent was removed in vacuo, the residue dissolved in water, and made acidic with 2 N hydrochloric acid (4.7 ml). The resulting precipitate was extracted with ethyl acetate, and the organic phase dried over anhydrous sodium sulfate. After removing the solvent in vacuo, a foam was triturated with diethyl ether for 18 hours and filtered to give a crude product (0.69 g). The crude product was purified by treatment with activated charcoal in methanol. Crystallization from methanol/ether afforded the title compound as a purified solid (0.29 g), m.p. 198-199° C.; MS (EI), m/z: 366 (M)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06511974B1 |
|---|
| Source dataset | uspto-grants-2003_01 |
|---|
| ORD ID | ord-fd53fba7e6ff449a9698fe63f7f4556b |
|---|
| Source note | uspto-grants-2003_01 |
|---|